Showing results (51-60 of 92) with videos related to
Sort By:
Pageof 10
Journal of the Endocrine Society|December 22, 2017
Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral PheochromocytomasKelly Lauter Roszko, Erica Blouch, Michael Blake, et al.Archives of Pathology & Laboratory Medicine|January 31, 2014
Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomasOzgur Mete, Arthur S Tischler, Ronald de Krijger, et al.Virchows Archiv : an International Journal of Pathology|August 9, 2008
Oncocytic adrenal cortical tumor with cytoplasmic inclusions and hyaline globulesTariq Al-Zaid, Joseph Alroy, Rolf Pfannl, et al.Endocrine-Related Cancer|May 29, 2020
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experienceElizabeth G Grubbs, Ronald M Lechan, Beth Edeiken-Monroe, et al.Journal of Molecular Neuroscience : MN|June 22, 2005
Nicotine stimulates expression of the PNMT gene through a novel promoter sequenceMarian J Evinger, Elizabeth Mathew, Stefan Cikos, et al.Endocrine Pathology|January 12, 2021
What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?Thomas G Papathomas, Diederik P D Suurd, Karel Pacak, et al.Cell and Tissue Research|May 5, 2010
Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medullaStephanie M J Fliedner, Jan Breza, Richard Kvetnansky, et al.Endocrinology|January 12, 2013
Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude miceAlessio Giubellino, Petra Bullova, Svenja Nölting, et al.Endocrine-Related Cancer|July 4, 2018
A unique model for SDH-deficient GIST: an endocrine-related cancerJames F Powers, Brent Cochran, James D Baleja, et al.Pituitary|February 8, 2007
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonistsLisa M Neff, Michelle Weil, Alan Cole, et al.Pageof 10